TABLE 2.
PLA30 min | PBMT30 min | PLA6 h | PBMT6 h | ANOVA | ||||
Main Effect: Time | Main Effect: Condition | Interaction: Time × Condition | ||||||
pH (a.u.) | Rest | 7.46 ± 0.03 (7.44 to 7.48) |
7.47 ± 0.02 (7.45 to 7.49) |
7.46 ± 0.03 (7.44 to 7.48) |
7.46 ± 0.03 (7.44 to 7.48) |
p < 0.01 = 0.83 |
p = 0.74 = 0.04 |
p = 0.26 = 0.14 |
Exercise | 7.34 ± 0.06 (7.30 to 7.38) |
7.34 ± 0.04 (7.31 to 7.37) |
7.35 ± 0.04 (7.32 to 7.38) |
7.35 ± 0.05 (7.32 to 7.39) |
||||
Δ% | −1.56 ± 0.97 (−2.18 to −0.94) |
−1.77 ± 0.67 (−2.20 to −1.35) |
−1.42 ± 0.81 (−1.94 to −0.90) |
−1.47 ± 0.77 (−1.97 to −0.98) |
p = 0.26 = 0.14 |
|||
(mmol/L) | Rest | 26.21 ± 2.20 (24.81 to 27.61) |
26.85 ± 1.45 (25.92 to 27.77) |
27.00 ± 1.69 (25.90 to 28.08) |
26.74 ± 1.50 (25.78 to 27.69) |
p < 0.01 = 0.97 |
p = 0.26 = 0.11 |
p = 0.55 = 0.06 |
Exercise | 19.10 ± 2.23 (17.68 to 20.51) |
18.50 ± 1.52 (17.53 to 19.47) |
19.21 ± 1.10 (18.51 to 19.91) |
19.38 ± 1.28 (18.56 20.20) |
||||
Δ% | −26.17 ± 15.41 (−35.97 to −16.38) |
−30.94 ± 6.01 (−34.77 to −27.21) | −28.63 ± 5.13 (−31.90 to −25.37) |
−27.39 ± 5.14 (−30.66 to −24.12) |
p = 0.46 = 0.06 |
|||
BE (mmol/L) | Rest | 2.46 ± 1.58 (1.40 to 3.52) |
2.73 ± 1.76 (1.55 to 3.92) |
2.70 ± 1.86 (1.45 to 3.96) |
2.75 ± 1.66 (1.63 to 3.87) |
p < 0.01 = 0.98 |
p = 0.33 = 0.11 |
p = 0.53 = 0.07 |
Exercise | −7.24 ± 2.11 (−8.66 to −5.82) |
−7.50 ± 2.16 (−8.96 to −6.05) |
−6.60 ± 1.37 (−7.53 to −5.68) |
−6.44 ± 1.81 (−7.66 to −5.22) |
||||
Δ% | −906.75 ± 1415.22 (−1857.51 to 44.00) |
−929.28 ± 1410.62 (−1876.95 to 18.39) |
−1200.53 ± 2176.54 (−2662.76 to 261.68) |
−450.81 ± 339.51 (−678.90 to −222.72) |
p = 0.62 = 0.05 |
|||
K+ (mmol/L) | Rest | 5.20 ± 0.43 (4.92 to 5.48) |
5.12 ± 0.93 (4.53 to 5.72) |
5.48 ± 0.73 (5.02 to 5.94) |
5.21 ± 0.59 (4.83 to 5.59) |
p < 0.01 = 0.68 |
p = 0.24 = 0.12 |
p = 0.22 = 0.11 |
Exercise | 5.67 ± 0.83 (5.14 to 6.20) |
6.25 ± 0.63 (5.85 to 6.65) |
5.97 ± 0.99 (5.34 to 6.60) |
5.96 ± 0.67 (5.53 to 6.39) |
||||
Δ% | 9.53 ± 16.82 (−1.15 to 20.22) |
24.40 ± 16.70 (13.79 to 35.02) |
10.26 ± 20.68 (−2.87 to 23.40) |
15.46 ± 15.88 (5.36 to 25.55) |
p = 0.15 = 0.15 |
|||
[La–]rest (mmol/L) | 0.71 ± 0.32 (0.51 to 0.91) |
0.98 ± 0.43 (0.72 to 1.24) |
0.97 ± 0.69 (0.55 to 1.39) |
0.76 ± 0.27 (0.59 to 0.93) |
p = 0.25 = 0.11 |
|||
AUC of [La–] (mmol/min) | 22.40 ± 8.58 (17.22 to 27.61) |
20.33 ± 7.81 (15.62 to 25.01) |
19.84 ± 7.72 (15.10 to 24.50) |
22.57 ± 11.64 (15.47 to 29.61) |
p = 0.56 = 0.05 |
|||
[La–]peak (mmol/L) | 12.23 ± 1.85 (11.12 to 13.31) |
12.39 ± 1.72 (11.30 to 13.39) |
12.45 ± 1.95 (11.30 to 13.60) |
12.33 ± 2.13 (11.04 to 13.6) |
p = 0.95 = 0.01 |
Values are expressed as Mean ± SD (CI95%). = partial eta squared; = sodium bicarbonate; BE = base excess; K+ = potassium ion; [La–]rest = blood lactate concentration at rest; [La–]peak = peak of blood lactate concentration; AUC = area under curve; PBMT30 min = photobiomodulation treatment 30 min before exercise; PLA30 min = placebo treatment 30 min before exercise; PBMT6 h = photobiomodulation treatmen 6 h before exercise; PLA6 h = placebo treatment 6 h before exercise. n = 13.